Histatin-5 vs BI 456906
Head-to-head comparison of Histatin-5 (Human histatin 5) and BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | BI 456906 |
|---|---|---|
| Category | Dental & Oral | Weight Management |
| Full Name | Human histatin 5 | BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist |
| Molecular Weight | 3035 Da | N/A |
| Half-Life | minutes in saliva | Approximately 1 week |
| Amino Acids | 24 | N/A |
| Typical Dose | 1-100 µM in research formulations | Trial-dependent; weekly SC dosing |
| Route | Topical/Oral rinse | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 10 |
| Research Status | Pre-clinical | Clinical |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
BI 456906 Benefits
- ✓weight reduction
- ✓improved glucose control
- ✓lower liver-fat burden
- ✓enhanced satiety
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
BI 456906 Dosing
once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
BI 456906 Side Effects
- ⚠nausea
- ⚠abdominal discomfort
- ⚠diarrhea
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
BI 456906
Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.